Assignment Mental Health Disordersa 38 Year Old Woman Presen

Assignment Mental Health Disordersa 38 Year Old Woman Presents To the Assignment Mental Health Disordersa 38 Year Old Woman Presents To the

A 38-year-old woman presents to the office with complaints of weight loss, fatigue, and insomnia of 3-month duration. She reports that she has been feeling gradually more tired and staying up late at night because she can’t sleep. She does not feel that she is doing as well in her occupation as a secretary and states that she has trouble remembering things. She does not go outdoors as much as she used to and cannot recall the last time she went out with friends or enjoyed a social gathering. She feels tired most of the week and states she feels that she wants to go to sleep and frequently does not want to get out of bed. She denies any recent medication, illicit drug, or alcohol use. She feels intense guilt regarding past failed relationships because she perceives them as faults. She states she has never thought of suicide, but has begun to feel increasingly worthless. Her vital signs and general physical examination are normal, although she becomes tearful while talking. Her mental status examination is significant for depressed mood, psychomotor retardation, and difficulty attending to questions. Laboratory studies reveal a normal metabolic panel, normal complete blood count, and normal thyroid functions.

Paper For Above instruction

The presentation of a 38-year-old woman with a constellation of symptoms—including persistent depressed mood, anhedonia, weight loss, insomnia, fatigue, cognitive impairment, and feelings of worthlessness—strongly suggests a diagnosis of major depressive disorder (MDD). This condition is characterized by a significant change in mood and functioning lasting at least two weeks and affecting various aspects of a person’s life, including occupational performance and social interactions (American Psychiatric Association, 2013). The patient’s lack of suicidal ideation, normal physical exam, and absence of medical or substance-related causes further support this diagnosis.

Major depressive disorder is prevalent across various demographic groups, with women showing higher lifetime risk compared to men (Kuehner, 2017). The risk factors include genetic predisposition, psychosocial stressors, and hormonal influences. Her symptoms of social withdrawal, decreased energy, cognitive impairment, and persistent guilt align with core clinical features outlined in DSM-5 criteria for MDD (American Psychiatric Association, 2013). Importantly, her symptoms have persisted for more than two months, fulfilling a key temporal criterion for diagnosis.

The next step in management involves confirming the diagnosis through a comprehensive clinical

assessment, including ruling out other potential causes such as thyroid dysfunctions or medical illnesses. Although initial laboratory findings are normal, further assessment might include screening for other psychiatric comorbidities like anxiety disorders or substance use, which can influence treatment decisions (McGorry & Nelson, 2019). Given her presentation, initiating pharmacotherapy with antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), is considered first-line treatment (Gelenberg et al., 2010). Psychotherapy, particularly cognitive-behavioral therapy (CBT), is also recommended as an adjunct or alternative, especially if she prefers non-pharmacological options.

Important considerations during treatment include monitoring for potential adverse effects of medication, such as increased anxiety or suicidal ideation, especially early in therapy. It is crucial to establish a therapeutic alliance, provide psychoeducation about depression, and regularly assess her response to treatment (Rush et al., 2006). Additionally, her social isolation warrants attention, and encouragement to re-engage in social activities can improve outcomes. For patients with depression, comorbidities like substance use or medical illnesses should be routinely screened for, as they can complicate management and prognosis.

Potential complications of management include inadequate treatment response, medication side effects, and the risk of suicidality. Although her current presentation does not indicate active suicidal ideation, she reports feelings of worthlessness, which necessitate close monitoring. Treatment-resistant depression may require augmentation strategies such as combination therapy or referral to specialized services. Long-term management also involves relapse prevention through psychoeducation, ongoing psychotherapy, and adherence to ongoing medication if indicated. Addressing underlying psychosocial stressors, stress management, and lifestyle modifications contribute substantially to sustained recovery.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Gelenberg, A. J., et al. (2010). Practice guideline for the treatment of patients with major depressive disorder.

American Journal of Psychiatry , 167(10), 1-151.

Kuehner, C. (2017). Why is depression more common among women than among men?

The Lancet Psychiatry , 4(2), 146-158.

McGorry, P., & Nelson, B. (2019). Early intervention in psychosis: concepts, evidence, and future directions.

World Psychiatry , 18(3), 273-284.

Rush, A. J., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

The American Journal of Psychiatry , 163(11), 1905-1917.